TrialThe Lancet. Neurology2014

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.

Adam L Boxer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.